MCID: VSM001
MIFTS: 38

Vasomotor Rhinitis

Categories: Respiratory diseases

Aliases & Classifications for Vasomotor Rhinitis

MalaCards integrated aliases for Vasomotor Rhinitis:

Name: Vasomotor Rhinitis 12 15 17 32
Rhinitis, Vasomotor 43 71
Rhinitis Vasomotor 54

Classifications:



External Ids:

Disease Ontology 12 DOID:4730
MeSH 43 D012223
NCIt 49 C34988
SNOMED-CT 67 8229003
ICD10 32 J30.0
UMLS 71 C0035460

Summaries for Vasomotor Rhinitis

Disease Ontology : 12 A rhinitis which involves a hypersensitive reaction to various potentially irritating stimuli such as changes in weather, temperature, or barometric pressure, chemical irritants such as smoke, ozone, pollution, perfumes, and aerosol sprays, psychological stress and emotional shocks, medications, alcohol, and spicy food.

MalaCards based summary : Vasomotor Rhinitis, also known as rhinitis, vasomotor, is related to chronic rhinitis and rhinitis. An important gene associated with Vasomotor Rhinitis is VIP (Vasoactive Intestinal Peptide), and among its related pathways/superpathways are Peptide ligand-binding receptors and G alpha (s) signalling events. The drugs Histamine and Azelastine have been mentioned in the context of this disorder. Affiliated tissues include testes, liver and skin.

Related Diseases for Vasomotor Rhinitis

Diseases related to Vasomotor Rhinitis via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 149, show less)
# Related Disease Score Top Affiliating Genes
1 chronic rhinitis 30.5 TAC1 RNASE3 IL5
2 rhinitis 30.5 VIP RNASE3 NPY KNG1 IL5
3 allergic rhinitis 30.0 VIP TAC1 RNASE3 KNG1 IL5 IL16
4 irritable bowel syndrome 30.0 VIP TRPV1 TAC1
5 urticaria 29.9 RNASE3 IL5 CD40LG
6 trigeminal neuralgia 29.9 TRPV1 TAC1 NPS CALCA
7 gastroesophageal reflux 29.8 VIP NPY IL5
8 allergic hypersensitivity disease 29.4 TAC1 RNASE3 KNG1 IL5
9 bronchitis 29.1 VIP TAC1 RNASE3 IL5 CD40LG CALCA
10 dermatitis, atopic 28.9 VIP TAC1 RNASE3 NPS IL5 IL16
11 asthma 26.8 VIP TRPV1 TAC1 RNASE3 NPY KNG1
12 pollen allergy 10.5
13 pancreatic somatostatinoma 10.4 VIP CALCA
14 somatostatinoma 10.4 VIP CALCA
15 endometrial small cell carcinoma 10.4 VIP TAC1
16 pancreatic cholera 10.4 VIP CALCA
17 endocrine pancreas disease 10.4 VIP CALCA
18 cluster headache 10.4 VIP CALCA
19 colon neuroendocrine neoplasm 10.4 VIP CALCA
20 paralytic ileus 10.4 VIP TAC1
21 prurigo nodularis 10.4 TAC1 RNASE3
22 functional gastric disease 10.3 VIP TAC1
23 autonomic nervous system benign neoplasm 10.3 VIP CALCA
24 hypereosinophilic syndrome 10.3
25 peripheral nervous system benign neoplasm 10.3 VIP CALCA
26 persian gulf syndrome 10.3 VIP NPS
27 neurodermatitis 10.3 TAC1 NPS
28 anisakiasis 10.3 RNASE3 CD40LG
29 aids phobia 10.3 TAC1 NPS
30 autonomic dysfunction 10.3
31 raynaud disease 10.3 CD40LG CALCA
32 maxillary sinusitis 10.3 RNASE3 CD40LG
33 erysipelas 10.3 CD40LG CALCA
34 cryptosporidiosis 10.2 VIP TAC1 CD40LG
35 interval angle-closure glaucoma 10.2 TAC1 KNG1
36 norwegian scabies 10.2 IL5 CD40LG
37 whiplash 10.2 KNG1 IL16
38 mikulicz disease 10.2 IL5 CD40LG
39 trichinosis 10.2 IL5 CD40LG
40 impetigo 10.2 CD40LG CALCA
41 viral meningitis 10.2 IL16 CD40LG CALCA
42 loeffler endocarditis 10.2 RNASE3 IL5
43 hyperhidrosis, gustatory 10.2 TRPV1 TAC1
44 pustulosis palmaris et plantaris 10.2 IL5 CD40LG
45 bursitis 10.2 TAC1 KNG1
46 atopic keratoconjunctivitis 10.2 RNASE3 IL5
47 carbamazepine allergy 10.2 TAC1 NPS CALCA
48 mite infestation 10.2 IL5 CD40LG
49 epicondylitis 10.2 TAC1 NPS CALCA
50 algoneurodystrophy 10.1 TAC1 NPS CALCA
51 chronic meningitis 10.1 IL5 CD40LG
52 dermatitis 10.1
53 atrophic rhinitis 10.1
54 vernal keratoconjunctivitis 10.1 RNASE3 IL5
55 disseminated eosinophilic collagen disease 10.1 RNASE3 IL5
56 pemphigoid gestationis 10.1 RNASE3 IL5
57 endomyocardial fibrosis 10.1 RNASE3 IL5
58 chronic cystitis 10.1 TRPV1 TAC1
59 intrinsic asthma 10.1 RNASE3 IL5
60 intussusception 10.1 VIP CD40LG
61 eosinophilic meningitis 10.1 IL5 CD40LG
62 paragonimiasis 10.1 RNASE3 IL5
63 elephantiasis 10.1 RNASE3 IL5
64 wells syndrome 10.1 RNASE3 IL5
65 collagenous colitis 10.1 RNASE3 CD40LG
66 vipoma 10.1 VIP CALCA
67 cow milk allergy 10.1 RNASE3 IL5
68 viral laryngitis 10.1 RNASE3 NPS CD40LG
69 henoch-schoenlein purpura 10.1 RNASE3 CD40LG
70 drug allergy 10.0 IL5 CD40LG
71 kimura disease 10.0 RNASE3 IL5
72 nerve compression syndrome 10.0 TRPV1 TAC1
73 intestinal schistosomiasis 10.0 IL5 CD40LG
74 chronic conjunctivitis 10.0 RNASE3 IL5
75 meningitis 10.0 IL5 CD40LG CALCA
76 chronic eosinophilic pneumonia 10.0 RNASE3 IL5
77 latex allergy 10.0 RNASE3 IL5
78 ige responsiveness, atopic 10.0
79 respiratory allergy 10.0
80 xerophthalmia 10.0
81 osteomyelitis 10.0
82 tonsillitis 10.0
83 keratoconjunctivitis sicca 10.0
84 hyperinsulinism 10.0
85 food allergy 10.0
86 sleep disorder 10.0
87 dystonia 10.0
88 47,xyy 10.0
89 argyria 10.0
90 detrusor sphincter dyssynergia 10.0 TRPV1 TAC1 CALCA
91 carcinoid syndrome 10.0 NPY CALCA
92 burning mouth syndrome 10.0 TRPV1 TAC1 CALCA
93 nasal cavity disease 10.0 TAC1 RNASE3 IL5
94 toxocariasis 10.0 RNASE3 IL5 CD40LG
95 mononeuropathy 10.0 TRPV1 TAC1 CD40LG
96 urinary schistosomiasis 10.0 RNASE3 IL5
97 aspiration pneumonia 10.0 TRPV1 TAC1 CD40LG
98 echinococcosis 10.0 RNASE3 IL5 CD40LG
99 conjunctival disease 10.0 RNASE3 IL5 CD40LG
100 churg-strauss syndrome 10.0 RNASE3 IL5 CD40LG
101 paranasal sinus disease 10.0 RNASE3 IL5 CD40LG
102 migraine with aura 10.0 VIP TAC1 NPS CALCA
103 parasitic helminthiasis infectious disease 10.0 RNASE3 IL5 CD40LG
104 cellulitis 9.9 RNASE3 IL5 CD40LG
105 gastroenteritis 9.9 RNASE3 IL5 CALCA
106 bronchiolitis 9.9 RNASE3 IL5 CD40LG
107 schistosomiasis 9.9 RNASE3 IL5 CD40LG
108 eosinophilic gastroenteritis 9.9 RNASE3 IL5
109 otitis media 9.9 RNASE3 IL5 CD40LG
110 allergic asthma 9.9 RNASE3 IL5 IL16
111 dental pulp disease 9.9 TRPV1 TAC1 NPS
112 upper respiratory tract disease 9.9 RNASE3 IL5 CD40LG
113 leprosy 2 9.9 VIP NPY CALCA
114 complex regional pain syndrome 9.8 TAC1 NPY CALCA
115 rabies 9.8 VIP NPY CD40LG
116 integumentary system disease 9.8 KNG1 IL5 CD40LG
117 interstitial cystitis 9.8 TRPV1 TAC1 KNG1
118 cystitis 9.8 TRPV1 TAC1 KNG1
119 nose disease 9.8 TAC1 RNASE3 IL5 CD40LG
120 bronchial disease 9.8 TAC1 RNASE3 IL5 CD40LG
121 sensory peripheral neuropathy 9.8 TRPV1 TAC1 CD40LG CALCA
122 respiratory failure 9.7 TAC1 RNASE3 IL5 CD40LG
123 status asthmaticus 9.7 RNASE3 IL5
124 causalgia 9.7 TRPV1 TAC1 NPS CALCA
125 trigeminal nerve disease 9.7 TRPV1 TAC1 NPS CALCA
126 hirschsprung disease 1 9.6 VIP TAC1 NPY CALCA
127 disease of mental health 9.6 TAC1 NPY NPS
128 skin disease 9.6 VIP TAC1 RNASE3 IL5 CD40LG
129 degenerative disc disease 9.6 TRPV1 NPY CALCA
130 reflex sympathetic dystrophy 9.5 TAC1 NPY NPS CALCA
131 cough variant asthma 9.5 TRPV1 TAC1 RNASE3 IL5
132 polyradiculopathy 9.5 TRPV1 TAC1 NPS CD40LG CALCA
133 pulpitis 9.4 TRPV1 KNG1
134 inflammatory bowel disease 9.4 VIP TAC1 IL5 IL16 CD40LG CALCA
135 diarrhea 9.4 TRPV1 TAC1 IL5 CD40LG CALCA
136 pheochromocytoma 9.4 VIP NPY KNG1 CALCA
137 myofascial pain syndrome 9.3 TRPV1 TAC1 NPS KNG1 CALCA
138 paine syndrome 9.3 TRPV1 TAC1 NPS KNG1 CALCA
139 somatoform disorder 9.3 TRPV1 TAC1 NPS KNG1 CALCA
140 pain agnosia 9.3 TRPV1 TAC1 NPS KNG1 CALCA
141 agnosia 9.3 TRPV1 TAC1 NPS KNG1 CALCA
142 pulmonary disease, chronic obstructive 9.3 TRPV1 TAC1 RNASE3 IL5 IL16
143 specific developmental disorder 9.3 TRPV1 TAC1 NPY NPS
144 constipation 9.2 VIP TRPV1 TAC1 NPY CALCA
145 perianal hematoma 9.2 TAC1 NPY NPS KNG1 CALCA
146 autonomic nervous system disease 9.1 TRPV1 TAC1 NPY NPS CALCA
147 peripheral nervous system disease 9.1 TRPV1 TAC1 NPS KNG1 CD40LG CALCA
148 hypertension, essential 8.7 VIP TAC1 NPY NPS KNG1 CD40LG
149 migraine with or without aura 1 8.3 VIP TRPV1 TAC1 NPY NPS KNG1

Graphical network of the top 20 diseases related to Vasomotor Rhinitis:



Diseases related to Vasomotor Rhinitis

Symptoms & Phenotypes for Vasomotor Rhinitis

Drugs & Therapeutics for Vasomotor Rhinitis

Drugs for Vasomotor Rhinitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 48, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Histamine Approved, Investigational Phase 4 51-45-6 774
2
Azelastine Approved Phase 4 58581-89-8 2267
3
Montelukast Approved Phase 4 158966-92-8 5281040
4 Analgesics, Non-Narcotic Phase 4
5 Olopatadine Hydrochloride Phase 4
6 Respiratory System Agents Phase 4
7 Neurotransmitter Agents Phase 4
8 Anti-Asthmatic Agents Phase 4
9 Anti-Allergic Agents Phase 4
10 Histamine H1 Antagonists Phase 4
11 Histamine H1 Antagonists, Non-Sedating Phase 4
12 Histamine Antagonists Phase 4
13
Histamine Phosphate Phase 4 51-74-1 65513
14 Analgesics Phase 4
15 Anti-Inflammatory Agents Phase 4
16 Bronchodilator Agents Phase 4
17 Anti-Inflammatory Agents, Non-Steroidal Phase 4
18 Antirheumatic Agents Phase 4
19 Hormone Antagonists Phase 4
20 Leukotriene Antagonists Phase 4
21 Hormones Phase 4
22 Vaccines Phase 4
23 Immunologic Factors Phase 4
24
Levocetirizine Approved Phase 3 130018-77-8 1549000
25
Pseudoephedrine Approved Phase 3 90-82-4 7028
26
Ephedrine Approved Phase 3 299-42-3 9294
27
Phenylephrine Approved Phase 3 59-42-7 6041
28
Oxymetazoline Approved, Investigational Phase 3 1491-59-4 4636
29 Central Nervous System Stimulants Phase 3
30 Nasal Decongestants Phase 3
31 Adrenergic Agents Phase 3
32 Vasoconstrictor Agents Phase 3
33 Sympathomimetics Phase 3
34 Adrenergic alpha-Agonists Phase 3
35 Cardiotonic Agents Phase 3
36 Adrenergic Agonists Phase 3
37 Protective Agents Phase 3
38 Mydriatics Phase 3
39 Pharmaceutical Solutions Phase 3
40
Capsaicin Approved Phase 1 404-86-4 1548943
41
Esomeprazole Approved, Investigational 161796-78-7, 119141-88-7, 161973-10-0 9568614 4594
42
Isotretinoin Approved 4759-48-2 5282379 5538
43 Antacids
44 Anti-Ulcer Agents
45 Gastrointestinal Agents
46 Proton Pump Inhibitors
47 Dermatologic Agents
48 Liver Extracts

Interventional clinical trials:

(showing 16, show less)
# Name Status NCT ID Phase Drugs
1 Safety and Efficacy of Olopatadine 0.6% and Azelastine 137 Mcg in Vasomotor Rhinitis Completed NCT00979615 Phase 4 Olopatadine HCL (Patanase) Nasal Spray, 0.6%;Azelastine HCl (Astelin) Nasal Spray, 137 mcg
2 The Effects of Alvokast (Montelukast) in Patients With Chronic Cough Completed NCT01754220 Phase 4 Montelukast
3 Grass Pollen Subcutaneous Immunotherapy: a Double-blind, Placebo-controlled Study in Elderly Patients With an Allergy to Grass Pollen Completed NCT02440243 Phase 4 Purethal;Purethal -placebo
4 A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis Completed NCT00118703 Phase 3 GW685698X
5 A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis Completed NCT00117325 Phase 3 GW685698X
6 Efficacy and Safety of Cossac L Tablet in Vasomotor Rhinitis Patients : A Randomized, Double-blind, Placebo-controlled, Phase 3 Clinical Trial Completed NCT01509209 Phase 3 Pseudoephedrine / Levocetirizine
7 Impact of Acupuncture on Vasomotor Rhinitis: a Randomised Placebo Controlled Pilot Study Completed NCT00682162 Phase 3
8 A Randomized, Two-Way Crossover, Multicenter, Consumer Preference Study of Two Oral Formulations of Phenylephrine Hydrochloride. Completed NCT00976209 Phase 3 Phenylephrine Hydrochloride (HCl) Extended Release (ER) Tablets 30 mg;Phenylephrine Hydrochloride (HCl) Immediate Release (IR) tablets, 10 mg
9 Phase III Randomized Open-label Clinical Trial Comparing Cleanoze® Irrigation Device With Powder Preparation Versus Conventional Irrigation Method for Chronic Rhinitis Completed NCT02763241 Phase 3 Cleanoze®;Saline (Syringe irrigation)
10 Tolerability of Intranasal Capsaicinoid Spray Recruiting NCT03952845 Phase 1
11 Efficacy of Esomeprazole for Non-Allergic Rhinitis: A Double-blind, Placebo Controlled Trial Completed NCT00745849 esomeprazole;placebo
12 Nasal Physiologic Reactivity of Nonallergic Rhinitics to Cold Air Provocation Completed NCT00415493
13 Nasal Saline Irrigation After Radiation Therapy for Oropharyngeal Cancer: A Pilot Study Completed NCT02338102
14 Reproducibility of Cell Counts in Nasal Lavage: A Comparison of Pooled Versus Non-Pooled Nasal Lavage Samples Completed NCT00229190
15 DUAL BRAVO PH MONITORING: A Feasibility Trial Completed NCT00378898
16 Treatment of Acne Vulgaris Using 1,565 nm Non-ablative Fractional Laser in Combination With Isotretinoin and Pricking Blood Therapy Completed NCT04156815 Oral isotretinoin

Search NIH Clinical Center for Vasomotor Rhinitis

Inferred drug relations via UMLS 71 / NDF-RT 50 :


azelastine
Azelastine hydrochloride
Brompheniramine
Brompheniramine Maleate
carbinoxamine
Carbinoxamine maleate
Ipratropium
Ipratropium Bromide
Phenylephrine
Phenylephrine bitartrate
Phenylephrine Hydrochloride
Phenylephrine Tannate
Phenylpropanolamine Hydrochloride
Scopolamine
Scopolamine Hydrobromide
tetrahydrozoline
Tetrahydrozoline hydrochloride

Cochrane evidence based reviews: rhinitis, vasomotor

Genetic Tests for Vasomotor Rhinitis

Anatomical Context for Vasomotor Rhinitis

MalaCards organs/tissues related to Vasomotor Rhinitis:

40
Testes, Liver, Skin, Cortex, Heart, Thyroid, Tonsil

Publications for Vasomotor Rhinitis

Articles related to Vasomotor Rhinitis:

(showing 655, show less)
# Title Authors PMID Year
1
[The roles of three peptides in the pathogenesis of vasomotor rhinitis]. 54 61
17087112 2006
2
Eosinophil inflammation of the nasal mucosa in allergic and non-allergic rhinitis measured by eosinophil cationic protein levels in native nasal fluid and serum. 54 61
7889429 1994
3
Laser ablation of posterior nasal nerves for rhinitis. 61
31948695 2020
4
Ultrasound-guided acupuncture of the sphenopalatine ganglion for the treatment of vasomotor rhinitis: a case report. 61
32233776 2020
5
Newer Surgical Options for Nasal Allergy. 61
32158670 2020
6
Rhinorrhea as a Result of Alzheimer's Disease Treatment: A Case Report. 61
31818352 2019
7
Voice After Rhinoplasty. An Important Question for the Opera Singers. 61
31889647 2019
8
Asthma and allergies in pregnancy. 61
31690383 2019
9
Intranasal corticosteroids for non-allergic rhinitis. 61
31677153 2019
10
Allergic and nonallergic rhinitis. 61
31690374 2019
11
[Endoscopic posterior nasal neurectomy]. 61
31439065 2019
12
[Application of nasal saline irrigation in nasal inflammatory diseases]. 61
30669208 2019
13
[Therapeutic effect of nasal corticosteroids combined with nasal antihistamine on vasomotor rhinitis]. 61
30550209 2018
14
Cryotherapy for the Treatment of Chronic Rhinitis: A Qualitative Systematic Review. 61
30229670 2018
15
Surgical Management of Nonallergic Rhinitis. 61
29937065 2018
16
[Treatment of allergic and vasomotor rhinitis: the role of beclomethasone dipropionate and hyaluronic acid (with high molecular weight).] 61
29689043 2018
17
[Innovative technology full volume lavage of the nasal cavity in the treatment of allergic and vasomotor rhinitis]. 61
30412178 2018
18
[Cryosurgery in the treatment of allergic and non-allergic rhinitis]. 61
30267489 2018
19
[A variant of the modification of the rhinosurgical intervention with the use of the hemostatic glue]. 61
30412179 2018
20
[Research advances of pregnancy rhinitis]. 61
29798199 2017
21
Prognostic value of nasal cytology and clinical factors in nasal polyps development in patients at risk: can the beginning predict the end? 61
28665504 2017
22
[Clinical symptoms and immunology inspection characteristics of nasal cavity local allergy]. 61
29798346 2017
23
[Nasal irrigation for the treatment of vasomotor rhinitis: a pilot study]. 61
28635218 2017
24
[Nasal turbinate surgery]. 61
28401248 2017
25
Nasal Muco-ciliary transport time alteration: efficacy of 18 B Glycyrrhetinic acid. 61
29209499 2017
26
A Pilot Study Investigating Clinical Responses and Biological Pathways of Azelastine/Fluticasone in Nonallergic Vasomotor Rhinitis before and after Cold Dry Air Provocation. 61
28787742 2017
27
Combination therapy in allergic rhinitis: What works and what does not work. 61
28124648 2016
28
Severity of nasal obstruction can predict the anxiety status of patients with allergic rhinitis but not patients with vasomotor rhinitis. 61
27277070 2016
29
Is the location of a septal deviation associated with the degree of postoperative pain after septoplasty? 61
27792832 2016
30
Inferior Turbinate Hypertrophy in Rhinoplasty: Systematic Review of Surgical Techniques. 61
27556616 2016
31
Pathogenesis of rhinitis. 61
27434218 2016
32
NASAL cytology: practical aspects and clinical relevance. 61
27009397 2016
33
Nonallergic Rhinitis: Treatment. 61
27083104 2016
34
[Acute respiratory viral infections: Topical issues of diagnosis, prevention and treatment in therapeutic practice]. 61
28005035 2016
35
[About the unresolved problems of terminology and classification of allergic rhinitis and the desirability of distinguishing the mixed form of the disease]. 61
27876734 2016
36
Association between vasomotor rhinitis and irritable bowel syndrome. 61
28683253 2016
37
Vitamin D serum levels in children with allergic and vasomotor rhinitis. 61
26512257 2015
38
Endoscopic vidian neurectomy: a prospective case series. 61
25732231 2015
39
Surgical management of vasomotor rhinitis: a systematic review. 61
25785754 2015
40
[The disturbances of vegetative homeostasis in the children suffering from vasomotor rhinitis]. 61
26145742 2015
41
[The modern approach to the treatment of the patients presenting with vasomotor rhinitis with the use of the electrosurgical technique]. 61
26145748 2015
42
[The topical treatment of allergic and vasomotor rhinitis: the role of beclomethasone dipropionate]. 61
25424236 2014
43
"Overlapped" rhinitis: a real trap for rhinoallergologists. 61
25398169 2014
44
Rhinorrhea triggered by obturator prosthesis after surgical intervention of partial maxillary resection: a clinical report. 61
25503096 2014
45
[Diagnosis and clinical characteristics of patients with non-allergic rhinitis]. 61
25241870 2014
46
Long-term, randomized safety study of MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) in subjects with chronic rhinitis. 61
24607046 2014
47
Therapeutic effectiveness of endoscopic vidian neurectomy for the treatment of vasomotor rhinitis. 61
24433056 2014
48
[The clinical and functional evaluation of the combined treatment of vasomotor rhinitis in the children]. 61
25377674 2014
49
Intranasal capsaicin in management of nonallergic (vasomotor) rhinitis. 61
24941668 2014
50
High-content pSTAT3/1 imaging assays to screen for selective inhibitors of STAT3 pathway activation in head and neck cancer cell lines. 61
24127660 2014
51
[Suggestion on the diagnosis and treatment of vasomotor rhinitis]. 61
24444630 2013
52
Effect of intranasal azelastine on substance P release in perennial nonallergic rhinitis patients. 61
24274229 2013
53
MP29-02: a breakthrough for the treatment of allergic rhinitis. 61
23977840 2013
54
Endoscopic vidian neurectomy assisted by power instrumentation and coblation. 61
23806808 2013
55
Nonallergic rhinitis: therapeutic options. 61
23756873 2013
56
Sneezing and runny nose: should allergy testing be routinely performed? 61
24427659 2013
57
Chapter 14: Nonallergic rhinitis. 61
29021040 2013
58
Chapter 14: Nonallergic rhinitis. 61
23711042 2013
59
When sneezing indicates the cell type. 61
23193018 2013
60
Spa therapy of upper respiratory tract inflammations. 61
22588193 2013
61
[The complications of laser surgery for the treatment of chronic vasomotor rhinitis]. 61
23528475 2013
62
[Effect of posterior nasal neurectomy combined with the inferior turbinate surgery for the patients with perennial allergic rhinitis or vasomotor rhinitis]. 61
23470425 2013
63
[The role of vegetative tone in the pregnant women in the development of vasomotor rhinitis]. 61
23528468 2013
64
[The original splint-electrode for endonasal electrophoresis]. 61
24005276 2013
65
Traumatic unilateral vasomotor rhinitis. 61
23288805 2012
66
Severe unilateral vasomotor rhinitis: an antecedent sign of vascular compromise? 61
22672492 2012
67
The pterygopalatine ganglion and its role in various pain syndromes: from anatomy to clinical practice. 61
21956040 2012
68
Sphenopalatine artery ligation with nerve resection in patients with vasomotor rhinitis and polyposis: a prospective, randomized, double-blind investigation. 61
22339556 2012
69
A multiallergen and miniscreen can change primary care provider diagnosis and treatment of rhinitis. 61
22643950 2012
70
Chapter 6: Nonallergic rhinitis. 61
22794679 2012
71
Clinical effect of pricking blood at neiyingxiang (ExHN 9) on non-allergic rhinopathy: study protocol for a randomized controlled trial. 61
22500643 2012
72
Measurements of nasal fractional exhaled nitric oxide with a hand-held device in patients with allergic rhinitis: relation to cedar pollen dispersion and laser surgery. 61
22015565 2012
73
Inflammatory cell patterns in the nasal mucosa of patients with idiopathic rhinitis. 61
22487278 2012
74
TLR4 and TLR9 Expression in Different Phenotypes of Rhinitis. 61
22577387 2012
75
Cytologic alterations in nasal mucosa after sphenopalatine artery ligation in patients with vasomotor rhinitis. 61
22391083 2012
76
[Ultrasonic therapy of vasomotor rhinitis in combination with the application of topical corticosteroids]. 61
22951686 2012
77
Safe use of bipolar radiofrequency induced thermotherapy (RFITT) for nasal surgery in patients with cochlear implants. 61
21641135 2011
78
Nonallergic rhinopathy (formerly known as vasomotor rhinitis). 61
21737036 2011
79
Management of rhinitis: allergic and non-allergic. 61
21738880 2011
80
[Comparative assessment of cryosurgical treatment results in allergic and non-allergic rhinitis]. 61
22000145 2011
81
Olopatadine 0.6% nasal spray protects from vasomotor challenge in patients with severe vasomotor rhinitis. 61
21819751 2011
82
Two-week comparison study of olopatadine hydrochloride nasal spray 0.6% versus azelastine hydrochloride nasal spray 0.1% in patients with vasomotor rhinitis. 61
21352639 2011
83
Endoscopic anatomy of the postganglionic pterygopalatine innervation of the posterolateral nasal mucosa. 61
22287329 2011
84
[Evaluation of nasal patency in patients with vasomotor rhinitis]. 61
21215046 2010
85
[Recent progress in pathophysiological study of vasomotor rhinitis]. 61
21215065 2010
86
Local production of IgE in the respiratory mucosa and the concept of entopy: does allergy exist in nonallergic rhinitis? 61
20934624 2010
87
[Non-allergic chronic rhinitis]. 61
21255517 2010
88
Epidemiology and burden of nasal congestion. 61
20463822 2010
89
Vasomotor rhinitis. 61
20425499 2010
90
Non-allergic rhinitis: a case report and review. 61
20181075 2010
91
The treatment of vasomotor rhinitis with intranasal corticosteroids. 61
24228841 2009
92
The role of antihistamines in the treatment of vasomotor rhinitis. 61
24228781 2009
93
Consensus Description of Inclusion and Exclusion Criteria for Clinical Studies of Nonallergic Rhinopathy (NAR), Previously Referred to as Vasomotor Rhinitis (VMR), Nonallergic Rhinitis, and/or Idiopathic Rhinitis. 61
24228856 2009
94
Consensus Review and Definition of Nonallergic Rhinitis With a Focus on Vasomotor Rhinitis, Proposed to Be Known henceforth as Nonallergic Rhinopathy: Introduction to Part 2. 61
24228749 2009
95
Consensus Review and Definition of Nonallergic Rhinitis With a Focus on Vasomotor Rhinitis, Proposed to be Known henceforth as Nonallergic Rhinopathy Part 1. Introduction. 61
24229340 2009
96
Classification of Nonallergic Rhinitis Syndromes With a Focus on Vasomotor Rhinitis, Proposed to be Known henceforth as Nonallergic Rhinopathy. 61
24229372 2009
97
Characteristics of nonallergic vasomotor rhinitis. 61
24228982 2009
98
Consensus Definition of Nonallergic Rhinopathy, Previously Referred to as Vasomotor Rhinitis, Nonallergic Rhinitis, and/or Idiopathic Rhinitis. 61
24229320 2009
99
Epidemiology of vasomotor rhinitis. 61
24229078 2009
100
Psychological implications in ENT diseases. 61
23120613 2009
101
Impact of acupuncture on vasomotor rhinitis: a randomized placebo-controlled pilot study. 61
19388861 2009
102
Weather/temperature-sensitive vasomotor rhinitis may be refractory to intranasal corticosteroid treatment. 61
19463202 2009
103
Nonallergic rhinitis, with a focus on vasomotor rhinitis: clinical importance, differential diagnosis, and effective treatment recommendations. 61
23282951 2009
104
[Microcirculation in nasal mucosa of healthy subjects and patients with rhinitis and maxillary sinusitis]. 61
19692955 2009
105
[Experience with the use of surgical lasers for the treatment of patients with upper respiratory tract and ear diseases]. 61
19738589 2009
106
Pharmacokinetic characteristics and safety and tolerability of a reformulated azelastine hydrochloride nasal spray in patients with chronic rhinitis. 61
19220164 2009
107
[Mucociliary clearance in chronic hypertrophic and chronic vasomotor rhinitis in the light of morphometric data]. 61
20037550 2009
108
The prevalence of nasal symptoms attributed to allergies in the United States: findings from the burden of rhinitis in an America survey. 61
19173786 2008
109
Effectiveness of twice daily azelastine nasal spray in patients with seasonal allergic rhinitis. 61
19209282 2008
110
Olfactory receptor gene polymorphisms and nonallergic vasomotor rhinitis. 61
18446592 2008
111
[Efficacy evaluation of polysaccharide nucleic acid-fraction of BCG on vasomotor rhinitis]. 61
18476606 2008
112
[The role of neurovegetative disturbances in the clinical picture and treatment of vasomotor rhinitis]. 61
19156113 2008
113
[Haloinhalation therapy of patients with allergic and vasomotor rhinitis]. 61
18833128 2008
114
[Autotraining as an assisting method in treatment of vasomotor rhinitis]. 61
18839453 2008
115
Pediatric selective IgM immunodeficiency. 61
19043622 2008
116
[Septal stents--a perspective tamponadeless management of patients after septoplasty]. 61
18833097 2008
117
A novel and effective approach to treating rhinitis with nasal antihistamines. 61
18051206 2007
118
[The expression of serum IL-10,12,13,16 in patients with allergic rhinitis and vasomotor rhinitis]. 61
18254318 2007
119
Azelastine hydrochloride: a review of pharmacology, pharmacokinetics, clinical efficacy and tolerability. 61
17723160 2007
120
[Therapeutic effect of vadian neurectomy under the nasal endoscope on the vasomotor rhinitis]. 61
18007095 2007
121
Nasal hyperreactivity in allergic and non-allergic rhinitis: a potential risk factor for non-specific building-related illness. 61
17661929 2007
122
Meta-analysis of azelastine nasal spray for the treatment of allergic rhinitis. 61
17542768 2007
123
Review of azelastine nasal spray in the treatment of allergic and non-allergic rhinitis. 61
17376024 2007
124
Comparison of long term results after Ho:YAG and diode laser treatment of hyperplastic inferior nasal turbinates. 61
17304563 2007
125
Patient satisfaction survey of outpatient-based topical local anesthetic KTP laser inferior turbinectomy: a prospective study. 61
17424880 2007
126
Altitude-related cough. 61
17196414 2007
127
Epithelial shedding of the inferior turbinate in perennial allergic and nonallergic rhinitis: a riddle to solve. 61
17224530 2007
128
Pattern of clinical features of chronic simple rhinosinusitis in Port Harcourt. 61
17319347 2006
129
Selective IgM immunodeficiency: retrospective analysis of 36 adult patients with review of the literature. 61
17201230 2006
130
Autonomic nervous system evaluation using heart rate variability parameters in vasomotor rhinitis patients. 61
17049152 2006
131
The effect of intranasal injection of botulinum toxin A on the symptoms of vasomotor rhinitis. 61
16935174 2006
132
Nasal cytobrush cytology: evaluation of the hyperchromatic supranuclear stria. 61
16901009 2006
133
Plain radiological profile of paranasal sinuses in chronic nasal diseases in University of Port Harcourt Teaching Hospital. 61
17111766 2006
134
[Idiopathic rhinitis]. 61
16685605 2006
135
Questionnaire evaluation and risk factor identification for nonallergic vasomotor rhinitis. 61
16680922 2006
136
Endoscopic vidian neurectomy. 61
16686388 2006
137
Acoustic rhinometry: should we be using it? 61
16467635 2006
138
[Diagnostic and treatment in nasal polyps of children treated in Wrocław ENT department in the years 1991-2001]. 61
17357659 2006
139
Chronic upper airway cough syndrome secondary to rhinosinus diseases (previously referred to as postnasal drip syndrome): ACCP evidence-based clinical practice guidelines. 61
16428694 2006
140
Nasal wall compliance in vasomotor rhinitis. 61
16141379 2006
141
CT assessment of the effect of fluticasone propionate aqueous nasal spray treatment on lower turbinate hypertrophy due to vasomotor rhinitis. 61
16308253 2006
142
Vasomotor rhinitis. 61
16190503 2005
143
Review of the pharmacology, clinical efficacy, and safety of azelastine hydrochloride. 61
20476933 2005
144
Persistent nonallergic rhinosinusitis. 61
15842962 2005
145
[Assessment of nasal obstruction treatment with the rhinomanometric examination]. 61
16161920 2005
146
Open-label evaluation of azelastine nasal spray in patients with seasonal allergic rhinitis and nonallergic vasomotor rhinitis. 61
15899111 2005
147
Radiofrequency for the treatment of vasomotor rhinitis. 61
16340279 2005
148
Immunohistochemical localization of 3-nitrotyrosine in the nasal respiratory mucosa of patients with vasomotor rhinitis. 61
15799577 2005
149
Inspiratory flow in the nose: a model coupling flow and vasoerectile tissue distensibility. 61
15333615 2005
150
Clinical study on the use of nozovent in a tertiary care setting. 61
16104488 2004
151
Itch and skin rash from chocolate during fluoxetine and sertraline treatment: case report. 61
15522120 2004
152
Association of autonomic dysfunction and mild obstructive sleep apnea. 61
15195047 2004
153
Vasomotor rhinitis update. 61
15167037 2004
154
NARES: a risk factor for obstructive sleep apnea? 61
15124166 2004
155
Monosodium benzoate hypersensitivity in subjects with persistent rhinitis. 61
14763933 2004
156
Mechanisms of vasomotor rhinitis. 61
14984550 2004
157
Actual therapeutic management of allergic and hyperreactive nasal disorders. 61
22073046 2004
158
[Pathologic conditions associated with drug-induced rhinitis]. 61
15227959 2004
159
Treatment of nonallergic perennial rhinitis. 61
14984552 2004
160
Bioavailability and pharmacokinetics of intranasal hydromorphone in patients experiencing vasomotor rhinitis. 61
17523726 2004
161
[The influence of botulinum toxin type A on vasomotor rhinitis and morphological study]. 61
14971193 2003
162
Prenatal prediction of infant atopy by maternal but not paternal total IgE levels. 61
14610477 2003
163
Rhinitis in pregnancy. 61
14653050 2003
164
Ultrastructural and ultracytochemical study of the human nasal respiratory epithelium in vasomotor rhinitis. 61
14606598 2003
165
Interleukin (IL)-4 and to a lesser extent either IL-13 or interferon-gamma regulate the production of eotaxin-2/CCL24 in nasal polyps. 61
14510718 2003
166
Intrapharyngeal distribution of gastric acid refluxate. 61
12838017 2003
167
Vasomotor rhinitis is not a wastebasket diagnosis. 61
12759275 2003
168
Vasomotor rhinitis remains a true clinical problem. 61
12759276 2003
169
Rhinorrhea induced by loading of dental implants supporting an obturator prosthesis: a clinical report. 61
12806321 2003
170
Rhinitis: a dose of epidemiological reality. 61
12866316 2003
171
Vasomotor rhinitis should not be a wastebasket diagnosis. 61
12759277 2003
172
Azelastine nasal spray: a review of pharmacology and clinical efficacy in allergic and nonallergic rhinitis. 61
12776442 2003
173
[Nonallergic rhinitis with eosinophilia syndrome: state of knowledge]. 61
12741149 2003
174
Bipolar radiofrequency-induced thermotherapy of turbinate hypertrophy: pilot study and 20 months' follow-up. 61
12514396 2003
175
Orbital passage of pterygopalatine ganglion efferents to paranasal sinuses and nasal mucosa in man. 61
14707402 2003
176
Clinicocytological correlation in establishing the aetiology of chronic rhinitis. 61
12417775 2002
177
[Ho:YAG and diode laser treatment of hyperplastic inferior nasal turbinates]. 61
12173059 2002
178
Electrophoretic evaluation of nasal discharge in patients with allergic rhinitis and vasomotor rhinitis. 61
12141770 2002
179
Autonomic dysfunction, vasomotor rhinitis, and extraesophageal manifestations of gastroesophageal reflux. 61
11997777 2002
180
A characteristic protein in nasal discharge differentiating non-allergic chronic rhinosinusitis from allergic rhinitis. 61
12012948 2002
181
Increased epithelial cell proliferation in nasal polyps. 61
12051022 2002
182
[Features of predicting and control of clinico-functional states of patients with respiratory diseases during physical therapy]. 61
12132216 2002
183
[Characteristics of autonomic dystonia in children with vasomotor rhinitis]. 61
12227040 2002
184
Therapy choices beyond antihistamines. Vasomotor rhinitis. 61
12420500 2001
185
Histopathological verification of clinical indications to partial inferior turbinectomy. 61
11721505 2001
186
Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. 61
11449200 2001
187
Bilateral neurotrophic keratopathy complicating Vidian neurectomy. 61
11438063 2001
188
[Vascular effects of neurokinins in humans]. 61
11475796 2001
189
Vasomotor rhinitis: clinical efficacy of azelastine nasal spray in comparison with placebo. 61
11244365 2001
190
Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis. 61
11206234 2001
191
[Clinical and immunohistoenzymatic investigations in patients with vasomotor and perennial allergic rhinitis]. 61
15852783 2001
192
Autonomic nervous system evaluation of patients with vasomotor rhinitis. 61
11081594 2000
193
Nasal peak inspiratory flow through Turbuhaler in children with symptomatic rhinitis and in healthy children. 61
11110582 2000
194
Nasal congestion: a review of its etiology, evaluation, and treatment. 61
11011488 2000
195
Conventional versus endoscopic inferior turbinate reduction: technique and results. 61
11200717 2000
196
Ultracytochemical localization of the NADPH-d activity in the human nasal respiratory mucosa in vasomotor rhinitis. 61
10942142 2000
197
[Vasomotor rhinitis following endoscopic sinus surgery: 5 cases report]. 61
12541410 2000
198
Capsaicin significantly reduces sinonasal polyps. 61
11603795 2000
199
[Correction of microcirculatory disorders with low-energy laser radiation in children with vasomotor rhinitis]. 61
10771608 2000
200
Diode laser treatment of hyperplastic inferior nasal turbinates. 61
10960819 2000
201
Treatment of chronic rhinitis by an allergy specialist improves quality of life outcomes. 61
10619343 1999
202
Non-specific nasal provocation test with histamine. Analysis of the dose-response curve. 61
10670031 1999
203
Functional effects of neuropeptide Y receptors on blood flow and nitric oxide levels in the human nose. 61
10556147 1999
204
Ten days' use of oxymetazoline nasal spray with or without benzalkonium chloride in patients with vasomotor rhinitis. 61
10522506 1999
205
State and trait anxiety in women affected by allergic and vasomotor rhinitis. 61
10193919 1999
206
Vasomotor rhinitis following trauma to the nose. 61
10030243 1999
207
Effects of capsaicin pre-treatment in experimentally-induced secretory otitis media. 61
10396558 1999
208
Evaluation of rhinostereometry compared with acoustic rhinometry. 61
10728935 1999
209
Intranasal steroids and septum perforation--an overlooked complication? A description of the course of events and a discussion of the causes. 61
9830677 1998
210
Cough induced stress fracture and arthropathy of the ribs at extreme altitude. 61
9630030 1998
211
Measurement of nasal irritant sensitivity to pulsed carbon dioxide: a pilot study. 61
9546755 1997
212
Functional endoscopic sinus surgery in patients with sinugenic headache. 61
9277085 1997
213
Mucin mRNA expression in normal and vasomotor inferior turbinates. 61
9292181 1997
214
Capsaicin's effect on rat nasal mucosa substance P release: experimental basis for vasomotor rhinitis treatment. 61
9292182 1997
215
Vasomotor rhinitis and sphenopalatine ganglion block. 61
9204653 1997
216
CO2 laser surgery of hypertrophied inferior turbinates. 61
9200261 1997
217
[The evaluation of cellular immunity in patients with allergy to pollen]. 61
9757694 1997
218
Vanilloid receptors: new insights enhance potential as a therapeutic target. 61
9121806 1996
219
[Investigation of "anosmic zones" associated with nasal allergy]. 61
8969068 1996
220
[Functional problems before and after rhinoplasty]. 61
9183889 1996
221
A comparative immunological study of vasomotor rhinitis and pollinosis. 61
8844504 1996
222
Human nasal epithelium adsorbs complement C3-related fragments and expresses cell membrane complement regulatory proteins. 61
8628088 1996
223
Chronic sinusitis. 61
8594864 1996
224
Anterior ethmoidal glycerol rhizotomy for vasomotor rhinitis. 61
8536564 1995
225
Optimum treatment of rhinitis in the elderly. 61
8535047 1995
226
[The treatment of allergic vasomotor rhinitis: diagnostic problems and local immunotherapy]. 61
8561027 1995
227
[Treatment of nonspecific hyper-reflectory rhinopathy (vasomotor rhinitis) with capsaicin]. 61
7605568 1995
228
The role of the autonomic nerves in the control of nasal circulation. 61
8750945 1995
229
Rhinorrhea is decreased in dogs after nasal application of botulinum toxin. 61
7700663 1995
230
[Differentiation between allergic rhinitis and vasomotor rhinitis by electrophoretic evaluation of the protein in pituita]. 61
7738705 1995
231
Occupational rhinitis--possible mechanisms of pathogenesis. 61
7706912 1995
232
[Mastocytes in the diagnosis of chronic rhinitis]. 61
7565337 1995
233
Mast cells, eosinophils and IgE-positive cells in the nasal mucosa of patients with vasomotor rhinitis. An immunohistochemical study. 61
7537565 1995
234
[The effect of antibiotics on the body of those working in their manufacture]. 61
8779100 1995
235
[Ambulatory laser and turbinectomy in the treatment of nasal obstruction. Apropos of 68 cases]. 61
8561412 1995
236
Endoscopic transseptal vidian neurectomy. 61
7980900 1994
237
Local treatment of aspecific nasal hyperreactivity with capsaicin. 61
7892815 1994
238
Medical selection of military pilots: a Republic of Singapore Air Force perspective. 61
7847744 1994
239
[The treatment of atopic rhinitis in children with an accelerated variant of specific immunotherapy]. 61
7856017 1994
240
Bilateral transnasal vidian neurectomy in the management of chronic rhinitis. 61
7930892 1994
241
Nasal scarring by joss stick burns. 61
8057998 1994
242
[Variants of vasomotor rhinitis in children]. 61
7855995 1994
243
[Comparative value of skin tests and IgE antibodies in the serum in patients with chronic vasomotor rhinitis]. 61
7476701 1994
244
Comparison of allergic rhinitis and vasomotor rhinitis patients on the basis of a computer questionnaire. 61
8116859 1993
245
[Methods of treatment and drugs used in vasomotor rhinitis]. 61
8036758 1993
246
[Diagnosis of NARES by methacholine nasal provocative test]. 61
8315539 1993
247
An anatomical study of vidian neurectomy using an endoscopic technique: a potential new application. 61
8515510 1993
248
Acute frontal sinusitis: etiological factors and treatment outcome. 61
8475737 1993
249
[Medical treatment of vasomotor and allergic rhinitis]. 61
8317219 1993
250
Mast cell stabilizers. 61
1335142 1992
251
Rhinitis during pregnancy and rhinitis medicamentosa. 61
1281917 1992
252
Sensory, parasympathetic, and sympathetic neural influences in the nasal mucosa. 61
1460206 1992
253
Treatment of allergic and vasomotor rhinitis by the local application of different concentrations of silver nitrate. 61
1402359 1992
254
Upper thoracic sympathectomy for primary palmar hyperhidrosis: long-term follow-up. 61
1555100 1992
255
[Occurrence of asthma and non-infectious rhinitis in Denmark]. 61
1561074 1992
256
[Polyposis of the nasal sinuses. Epidemiology and clinical aspects of 350 cases. Treatment and results with a follow-up over 5 years on 93 cases]. 61
1485748 1992
257
Effects of capsaicin desensitization on nasal allergy-like symptoms and histamine release in the nose induced by toluene diisocyanate in guinea pigs. 61
1279933 1992
258
The spontaneous course of nasal obstruction in patients with normal nasal airway resistance. 61
1879078 1991
259
[Clinical effectiveness of magnetolaser therapy of vasomotor rhinitis]. 61
1862606 1991
260
[Perennial rhinopathy. A brief synopsis]. 61
2034931 1991
261
Treatment of 'vasomotor rhinitis' by the local application of silver nitrate. 61
2026942 1991
262
[Intranasal laser coagulation in the therapy of vasomotor rhinitis in elderly patients]. 61
2048258 1991
263
[Nasal provocation test with hyperosmolar solutions: normal values]. 61
1930907 1991
264
Alterations of adrenoceptors in the nasal mucosa of allergic patients in comparison with nonallergic individuals. 61
1847157 1991
265
Alterations of muscarinic acetylcholine receptors in the nasal mucosa of allergic patients in comparison with nonallergic individuals. 61
1993812 1991
266
The potassium--titanyl phosphate laser for treatment of turbinate dysfunction. 61
1901155 1991
267
[Differentiation between allergic rhinitis and vasomotor rhinitis. Light and electron microscopic studies]. 61
1888537 1991
268
Beneficial effects of intranasal applications of capsaicin in patients with vasomotor rhinitis. 61
1859650 1991
269
[Further investigation into the recurrent causes of post-vidian neurectomy and the feasibility of treating vasomotor rhinitis by surgery]. 61
1811678 1991
270
[Anterior ethmoidal electrocoagulation in the treatment of vasomotor rhinitis]. 61
1811691 1991
271
Neuropeptides and nasal secretion. 61
2229824 1990
272
[Methods of intranasal vibromassage]. 61
2267701 1990
273
[Functional methods of study in the evaluation of the effectiveness of laser therapy of vasomotor rhinitis and some forms of prosopalgia]. 61
2267688 1990
274
[Cryosurgery for the treatment of vasomotor rhinitis]. 61
2268463 1990
275
[Study of the changes in microcirculatory bed in children with vasomotor rhinitis based on biomicroscopy of conjunctival blood vessels]. 61
2238348 1990
276
Allergic and vasomotor rhinitis in asthmatics in the tropics and subtropics. 61
2360127 1990
277
Vasomotor rhinitis and the systemic absorption of ipratropium bromide. 61
2143593 1990
278
Rhinitis. 61
2196612 1990
279
[How can hyperreactive rhinopathy be modified surgically? II: Acoustic rhinometry and anterior turbinoplasty]. 61
2378653 1990
280
Vasomotor rhinitis with headshaking in a pony. 61
2361515 1990
281
[How can hyperreflexia rhinopathy be modified surgically? I. Literature review]. 61
2191677 1990
282
Chronic sinusitis. 61
21234027 1990
283
Diagnostic value of acoustic rhinometry: patients with allergic and vasomotor rhinitis compared with normal controls. 61
2336526 1990
284
Critical review of Vidian neurectomy. 61
2696076 1989
285
Rhinomanometric evaluation of two nasal steroid sprays in rhinitis. 61
2508019 1989
286
[Experience in the treatment of vasomotor rhinitis using the method of voluntary arrest of deep breathing]. 61
2588411 1989
287
[Aspecific rhinoreactivity in the diagnosis of vasomotor rhinopathy: rhinomanometric study]. 61
2626954 1989
288
[Etiopathogenesis and clinical aspects of allergic and vasomotor rhinopathy]. 61
2682853 1989
289
[Surgical treatment of vasomotor rhinitis]. 61
2529604 1989
290
Vasomotor rhinitis. 61
2663428 1989
291
[Carbachol nasal provocation test in vasomotor and polyposis rhinopathy]. 61
2763839 1989
292
Capsaicin and nicotine-sensitive afferent neurones and nasal secretion in healthy human volunteers and in patients with vasomotor rhinitis. 61
2720299 1989
293
Vasomotor rhinitis--atrophic rhinitis: two ends of an autonomic spectrum. 61
2595396 1989
294
Results obtained with Loderix tablet in chronic rhinitis patients. 61
2576575 1989
295
[Morphological changes in the nasal mucosa of workers in occupations exposed to dust]. 61
2628217 1989
296
[Status of the autonomic nervous system and reflexotherapy in children with vasomotor rhinitis]. 61
2587167 1989
297
[Indicators of the activity of the immune system during laser therapy of vasomotor rhinitis]. 61
2785311 1989
298
[Vasomotor rhinitis. Clinical study: an attempt at classification]. 61
2719192 1989
299
[Acupuncture--a method in the treatment of vasomotor rhinitis]. 61
2922937 1989
300
Nasal hyperreactivity to newspapers. 61
2702511 1989
301
Neuroimmune interactions in the airways: implications for asthma, allergy, and other inflammatory airway diseases. 61
3076481 1988
302
The effect of ipratropium bromide on nasal hypersecretion induced by methacholine in patients with vasomotor rhinitis. A double-blind, cross-over, placebo-controlled and randomized dose-response study. 61
2974675 1988
303
A comparative tolerance study of terfenadine-pseudoephedrine combination tablets and pseudoephedrine tablets in patients with allergic or vasomotor rhinitis. 61
2906887 1988
304
Eosinophilic nonallergic rhinitis. 61
3057047 1988
305
The effect of vidian neurectomy on nasal mucociliary clearance. 61
3199008 1988
306
[Status of systemic humoral and local immunity in children with vasomotor rhinitis]. 61
3227582 1988
307
[New aspects in the pathogenesis and therapy of hyperreflexive rhinopathy]. 61
3050340 1988
308
Headaches and sinus disease: the endoscopic approach. 61
3140703 1988
309
[Treatment of vasomotor rhinitis, trigeminal neuralgia and Sluder's syndrome by irradiation of the sphenopalatine ganglion with helium-neon lasers]. 61
3188323 1988
310
Chronic rhinitis in adults. 61
3286737 1988
311
[Vasomotor rhinitis]. 61
3393823 1988
312
A clinical follow-up of septal surgery with special attention to the value of preoperative rhinomanometric examination in the decision concerning operation. 61
3416503 1988
313
[The status of vitamin B 6 metabolism in patients with vasomotor rhinitis after cryotherapy followed by pyridoxine therapy]. 61
3388667 1988
314
The effect of inferior turbinate outfracture on nasal resistance to airflow in vasomotor rhinitis assessed by rhinomanometry. 61
3346593 1988
315
Is vidian neurectomy worthwhile? 61
3343567 1988
316
[Non-allergic eosinophilic rhinitis. From clinical diagnosis to pathogenic study]. 61
3064674 1988
317
Nasopharyngeal masses mimicking "allergic" nasal symptoms. 61
2826935 1988
318
The use of intranasal Atrovent in the treatment of vasomotor rhinitis. 61
2961291 1987
319
[Vasomotor rhinitis]. 61
3687160 1987
320
Control of the hypersecretion of vasomotor rhinitis by topical ipratropium bromide. 61
2957416 1987
321
Observations on headshaking in the horse. 61
3622462 1987
322
Nasal disorders in children. Allergic rhinitis, vasomotor rhinitis, and nasal polyps. 61
3588472 1987
323
Vasomotor rhinitis. 61
3111614 1987
324
[Use of prodektin in the treatment of children with vasomotor rhinitis]. 61
3617346 1987
325
[Vasomotor rhinitis in children]. 61
3649299 1987
326
[Use of intal electrophoresis in the combined treatment of patients with vasomotor rhinitis]. 61
3111084 1987
327
[Structural changes in the nasal mucosa in vasomotor rhinitis]. 61
3590493 1987
328
Turbinectomies for allergic and vasomotor rhinitis. 61
3830011 1987
329
[Treatment of patients with vasomotor rhinitis using snake venom]. 61
3551288 1987
330
[Catecholamine levels in vasomotor rhinitis]. 61
3684294 1987
331
Ultrastructural observations on vasomotor rhinitis. 61
3627734 1987
332
A trial of intranasal Atrovent versus placebo in the treatment of vasomotor rhinitis. 61
2946252 1986
333
[Microcirculation in patients with vasomotor rhinitis and its dynamics before and after the therapeutic use of laser irradiation]. 61
3811120 1986
334
Autonomic microganglia of the nasal mucosa and their relation to vasomotor rhinitis. 61
3780025 1986
335
[Histologic changes in the epithelium of the respiratory mucosa of the lower turbinates following argon laser strip carbonization in vasomotor rhinitis]. 61
3762277 1986
336
Timolol-induced vasomotor rhinitis: a new iatrogenic syndrome. 61
3729784 1986
337
[Immunopathologic aspects of vasomotor rhinitis. Therapeutic considerations]. 61
2947280 1986
338
Vasomotor rhinitis. 61
3951877 1986
339
[Clinical, diagnostic and therapeutic aspects of non-allergic forms of rhinitis: non-allergic rhinitis with eosinophilia syndrome and vasomotor rhinitis]. 61
2936989 1986
340
Autonomic dysfunction in perennial vasomotor rhinitis and the effect of mequitazine. 61
3816293 1986
341
Sarcoidosis in ENT practice. 61
3841652 1985
342
Vasomotor rhinitis. A review and management by intranasal cryotherapy. 61
4088111 1985
343
[The role of catecholamines in vasomotor rhinitis]. 61
4094903 1985
344
The effect of submucosal diathermy to the inferior turbinates on nasal resistance to airflow in allergic and vasomotor rhinitis. 61
4075549 1985
345
[Spasmophilia, vasomotor rhinitis and respiratory allergy]. 61
3832519 1985
346
[8 years' laser surgery of the inferior turbinates in vasomotor rhinopathy in the form of laser strip carbonization]. 61
4077599 1985
347
Laser turbinectomy as an adjunct to rhinoseptoplasty. 61
4015497 1985
348
[Method of treatment of vasomotor rhinitis]. 61
3876640 1985
349
1001 disorders of the ear, nose and sinuses in scuba divers. 61
4017159 1985
350
The effect of ipratropium bromide (Atrovent) on the air conditioning capacity of the nose. 61
3161669 1985
351
[Treatment and prevention of vasomotor rhinitis in children]. 61
3849433 1985
352
Histamine H1 receptors and affinity analyses in human nasal mucosa in cases of nasal allergy. 61
3994239 1985
353
[Hyperreflectoric rhinopathy]. 61
2579936 1985
354
Septilin and geriforte in allergic and vasomotor rhinitis. 61
2866761 1985
355
Non allergic rhinitis: demography of eosinophils in nasal smear, blood total eosinophil counts and IgE levels. 61
3870504 1985
356
[Zaditen (ketotifen) in the treatment of hay fever and vasomotor rhinitis]. 61
3912701 1985
357
Budesonide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in asthma and rhinitis. 61
6394263 1984
358
Pharmacologic treatment of rhinitis. 61
6149009 1984
359
Rhinitis in the athlete. 61
6143772 1984
360
[Resection of the vidian nerve in vasomotor rhinitis: morphofunctional effects on the nasal mucosa]. 61
6516838 1984
361
Transnasal preganglionic vidian nerve section. 61
6715981 1984
362
A comparison of some pharmacological actions of prostaglandin E1, 6-oxo-PGE1 and PGI2. 61
6203140 1984
363
Cryotherapy for chronic vasomotor rhinitis: technique and patient selection for improved results. 61
6708699 1984
364
Measurement of blood flow to human nasal mucosa in normal and pathological conditions by the use of the 133Xe clearance technique. 61
6732599 1984
365
Measurement of nasal mucociliary activity in man with 99mTc-labelled resin particles. 61
6732603 1984
366
[Pivalone and vasomotor rhinitis]. 61
6484351 1984
367
Intranasal ipratropium in the treatment of vasomotor rhinitis. 61
6229864 1983
368
Effect of a topical glucocorticoid, budesonide, on nasal mucosal blood flow as measured with 133Xe wash-out technique. 61
6356965 1983
369
Ipratropium (Atrovent) in the treatment of vasomotor rhinitis of elderly patients. 61
6228347 1983
370
Cryosurgery on postganglionic fibers (posterior nasal branches) of the pterygopalatine ganglion for vasomotor rhinitis. 61
6613543 1983
371
[Comparison of the significance of psychogenic factors in the etiopathogenesis of vasomotor rhinitis and hay fever]. 61
6866820 1983
372
Some immunological parameters in serum and nasal secretion in subjects with vasomotor and allergic rhinitis and nasal polyps - a comparative study. 61
6857102 1983
373
[Nasal provocation test in the diagnosis of vasomotor rhinitis]. 61
6880700 1983
374
Long-term treatment with budesonide in vasomotor rhinitis. 61
6829298 1983
375
The nasal passage following rhinoplastic surgery. 61
6822771 1983
376
Eosinophilic nonallergic rhinitis in children. 61
7110818 1982
377
[Etiopathogenetic aspects of vasomotor rhinitis]. 61
6222423 1982
378
[Cryosurgery in vasomotor rhinitis]. 61
7070689 1982
379
Local and serum IgE in vasomotor rhinitis. 61
7071466 1982
380
An evaluation of childhood rhinorrhea. 61
7055346 1982
381
[Evaluation of the role of difficult situations of psychic stress during vasomotor rhinitis (author's transl)]. 61
7099657 1982
382
Vasomotor rhinitis: an update. 61
7289692 1981
383
Timolol for vasomotor rhinitis. 61
7278906 1981
384
Nasal decongestants. 61
6166444 1981
385
Vascular effects of slow reacting substance (SRS) in the cat nasal mucosa and the appearance of a SRS-like principle in cat nasal secretion on nerve stimulation. 61
7315400 1981
386
[IgE values in nasal mucus in the diagnosis of perennial allergic rhinitis]. 61
7293876 1981
387
[Submucosal osteochonchotomy in vasomotor rhinitis]. 61
7222379 1981
388
[Value of vidian nerve resection in vasomotor rhinitis]. 61
7345597 1981
389
[Dexamethasone nose drops in the treatment of vasomotor rhinitis]. 61
7214570 1981
390
[Anterior rhinomanometry and intranasal challenge tests. Technique and results in 270 cases. Usefulness for the aetiological diagnosis of vasomotor rhinitis (author's transl)]. 61
7283331 1981
391
A comparison of cryosurgery and submucous diathermy in vasomotor rhinitis. 61
7441052 1980
392
[Argyria caused by uncontrolled use of silver protein in vasomotor rhinitis]. 61
7456246 1980
393
[Treatment of vasomotor rhinitis using an ultrasonic probe]. 61
7414831 1980
394
Allergic perennial and non-allergic, vasomotor rhinitis treated with budesonide nasal spray. 61
6997974 1980
395
Treatment of allergic and vasomotor rhinitis by the local application of silver nitrate. 61
7430808 1980
396
[Regional nasal blood supply and respiratory function in vasomotor rhinitis]. 61
7385528 1980
397
[Effectiveness of the cryosurgical treatment of vasomotor rhinitis]. 61
7385973 1980
398
Allergic and nonallergic rhinitis: their characterization with attention to the meaning of nasal eosinophilia. 61
6101336 1980
399
[Etiopathogenic diagnosis of vasomotor rhinitis]. 61
7457123 1980
400
Vasomotor rhinitis: neglected cause of nasal congestion. 61
6153128 1980
401
Long-term results of Vidian neurectomy. 61
523885 1979
402
[Freezing of the sphenopalatine ganglion in cryotherapy of vasomotor rhinitis]. 61
516240 1979
403
Treatment of obstructing inferior turbinates with intranasal corticosteroids. 61
543660 1979
404
Effect of 17 phenyl PGF2 alpha on nasal patency in man. 61
95330 1979
405
[Problems in the therapy of vasomotor rhinitis]. 61
88118 1979
406
Chronic vasomotor rhinitis: cryogenic and other surgical modes of treatment. 61
431262 1979
407
Vasomotor rhinitis--pathophysiological aspects. 61
34866 1979
408
Cryo surgery for allergic and vasomotor rhinitis. A new probe. 61
429897 1979
409
[Nasal cytology in vasomotor rhinitis]. 61
88705 1979
410
[(Intal (disodium cromoglycate) in the treatment of hay fever and vasomotor rhinitis]. 61
118418 1979
411
Corticosteroid injections of the nasal turbinates: past experience and precautions. 61
113742 1978
412
[Vasomotor rhinitis]. 61
747215 1978
413
Intraturbinal steroid injection: indications, results, and complications. 61
663723 1978
414
[Clinical effect of intranasal beclomethasone inhalations in chronic vasomotor rhinitis]. 61
349412 1978
415
[Vasomotor rhinitis and vasomotor tests (author's transl)]. 61
666223 1978
416
A comparative evaluation of oral decongestants in the treatment of vasomotor rhinitis. 61
627306 1978
417
[Technical details concerning vidian neurectomy by intranasal approach]. 61
655557 1978
418
[Electron microscopy of human nasal mucosa in disturbances of the autonomic nervous system. II. Parasympathetic denervation by vidian nerve transsection in vasomotor rhinitis (author's transl)]. 61
146131 1977
419
Acupuncture and phonostimulation in pollenosis and vasomotor rhinitis in the light of psychosomatic investigations. 61
920147 1977
420
[Endonasal Ar+-laser beam guide system and first clinical application in vasomotor rhinitis (author's transl)]. 61
143569 1977
421
What's New In ENT? 61
21304835 1977
422
Measurements of the air conditioning capacity of the nose during normal and pathological conditions and pharmacological influence. 61
578646 1977
423
[Pathogenetic problems of the changes in the paranasal sinuses in chronic vasomotor rhinitis]. 61
888285 1977
424
Cryotherapy as a method of treatment in allergic and vasomotor rhinitis. 61
874382 1977
425
[The stopped-up nose (vasomotor rhinitis)]. 61
586036 1977
426
Vasomotor rhinitis and nasal dyspnea. 61
862543 1977
427
A new syndrome characterised by absence of eosinophils and basophils. 61
68332 1977
428
[Use of long-wave ultraviolet radiation in the treatment of vasomotor rhinitis]. 61
878155 1977
429
[Cryotherapy in hyperthropic and vasomotor rhinitis]. 61
878612 1977
430
[Indices of blood lymphocyte blast transformation in chronic tonsillitis combined with vasomotor rhinitis with different treatment methods]. 61
867678 1977
431
[Electron microscopy of human nasal mucosa in disturbances of the autonomic nervous system. I. Sympathetic denervation (author's transl)]. 61
139514 1977
432
Treatment of vasomotor rhinitis with intranasal disodium cromoglycate (SCG). Results from a double-blind cross-over study. 61
402781 1977
433
Diphenylpyraline (Lergobine) in the treatment of patients suffering from allergic and vasomotor rhinitis. 61
14039 1977
434
[Corticosteroid treatment of pollinosis and vasomotor rhinitis]. 61
846736 1977
435
[Adrenal hormone and histamine content in children with vasomotor rhinitis]. 61
850964 1977
436
Vasomotor rhinitis: psychosomatic conditions and treatment. 61
12551 1976
437
[Treatment of vasomotor rhinitis in children]. 61
997081 1976
438
[Comparative allergologic studies in treated antihypertensive patients with vasomotor rhinitis]. 61
997665 1976
439
[The significance of IgE in the differential diagnosis of vasomotoric rhinopathy (author's transl)]. 61
134229 1976
440
The cholinergic nervous system and immediate hypersensitivity. 1. Eccrine sweat responses in allergic patients. 61
947982 1976
441
Intra-nasal beclomethasone dipropionate in vasomotor rhinitis. 61
782136 1976
442
Treatment of vasomotor rhinitis with intranasal beclomethasone dipropionate (Becotide). Results from a double-blind cross-over study. 61
782135 1976
443
[Histological and histoenzymatic study of the nasoturbinal mucosa in subjects with vasomotor rhinitis with neurotomy of the vidian nerve. Preliminary note]. 61
207204 1976
444
[Vascular reactions of the nasal mucosa in allergic and neuro-vegetative forms of vasomotor rhinitis]. 61
960436 1976
445
[Allergic rhinitis in children (author's transl)]. 61
786961 1976
446
[Influence of reserpine on the nasal mucous membrane (author's transl)]. 61
135141 1976
447
[Lunerin treatment in allergic and vasomotor rhinitis. A clinical evaluation]. 61
1267943 1976
448
Bilateral transnasal cauterization of the vidian nerve in vasomotor rhinitis. 61
1214107 1975
449
[Influence of endonasal corticosteroid therapy on the level of histamine in the blood of patients with vasomotor rhinitis]. 61
1227127 1975
450
Parasympathetic control of blood circulation and secretion in the nasal mucosa. 61
1224139 1975
451
Response of the human nasal mucous membrane to anti-human IgE serum. 61
1243638 1975
452
[Metabolism of serotonin and histamine in vasomotor rhinitis under the effect of cryotherapy]. 61
1231128 1975
453
[Vasomotor rhinitis: a side-effect of hormonal contraception? (author's transl)]. 61
1205995 1975
454
Vidian neurectomy. 61
1224122 1975
455
Double-blind comparison of metizoline hydrochloride (Ellsyl) and phenylephrine in allergic and vasomotor rhinitis. 61
49255 1975
456
[Condition of the nasal mucosa in patients with vasomotor rhinitis under the effect of cryotherapy]. 61
4432311 1974
457
[Corticosteroid therapy and 11-hydroxycorticosteroid content of blood plasma in patients with vasomotor rhinitis]. 61
4432314 1974
458
[Dynamics of vascular tonus of the nasal cavity under the effect of naphthysine in patients with vasomotor rhinitis]. 61
4432313 1974
459
[Effect of hormone therapy on the excretion of pregnanediol and 17-ketosteroids in patients with vasomotor rhinitis]. 61
4467421 1974
460
[Effect of general hormone therapy on the blood serotonin content in patients with vasomotor rhinitis]. 61
4467422 1974
461
[Local use of histaglobin in vasomotor rhinitis]. 61
4138115 1974
462
[Use of epsilon-aminocaproic acid in vasomotor rhinitis]. 61
4411429 1974
463
[Long-term results of various methods of treatment of vasomotor rhinitis]. 61
4767965 1973
464
Vidian neurectomy in vasomotor rhinitis. 61
4771966 1973
465
[Cryotherapy of vasomotor rhinitis]. 61
4767987 1973
466
[Submucous diathermic coagulation of nasal conchae in the treatment of vasomotor rhinitis]. 61
4762472 1973
467
An antihistamine-sympathomimetic amine combination in vasomotor rhinitis. 61
4147011 1973
468
A model for experimental vasomotor rhinitis. 61
4197086 1973
469
[Pregnanediol and 17-ketosteroid content in patients with vasomotor rhinitis]. 61
4774948 1973
470
[Cryotherapy in vasomotor rhinitis]. 61
4705374 1973
471
A placebo-controlled trial of imipramine in nonspecific vasomotor rhinitis. 61
4561390 1972
472
[Symptoms of vasomotor rhinitis of evaluation of the effect of conservative treatment]. 61
4404111 1972
473
A surgical approach to intractable vasomotor rhinitis. 61
5086892 1972
474
Experimental vasomotor rhinitis. 61
5036237 1972
475
[Carbohydrate metabolism in patients with vasomotor rhinitis in the course of hormonal therapy]. 61
5045813 1972
476
[Complex of respiratory symptoms and vasomotor rhinitis. Occurrence among workers of the Parintins jute factory, Amazons (June 1971)]. 61
5049285 1972
477
[Cryosurgery for the treatment of vasomotor rhinitis]. 61
5052203 1972
478
Experimental vasomotor rhinitis. 61
5015153 1972
479
The effect of triamcinolone acetonide on allergic and vasomotor rhinitis. 61
4551429 1972
480
Vasomotor rhinitis treated with Lunerin (Draco), a new sympathomimetic antihistaminic preparation. 61
4405524 1972
481
Chronic vasomotor rhinitis in the tropics. 61
4260855 1971
482
Treatment of vasomotor rhinitis with a combined antihistaminic--sympathomimetic preparation. 61
4402059 1971
483
[Current methods of treatment of allergic and vasomotor rhinitis]. 61
5152560 1971
484
[Blood serotonin in patients with vasomotor rhinitis]. 61
5152547 1971
485
[Acetylcholine-adrenaline test and latent bronchopulmonary spastic syndrome in cases with allergic vasomotor rhinitis]. 61
5564646 1971
486
Vasomotor rhinitis. 61
5280744 1971
487
[Role of the functional state of the adrenal cortex in the pathogenesis of vasomotor rhinitis]. 61
5552610 1971
488
Vasomotor rhinitis. 61
4395431 1970
489
[The role of thyroid dysfunction in the development of vasomotor rhinitis]. 61
5521615 1970
490
[Treatment of patients with vasomotor rhinitis with hydrocortisne phonophoresis]. 61
5449851 1970
491
Vidian neurectomy for vasomotor rhinitis: a review of 47 cases. 61
5443887 1970
492
[Comparative cytologic study of exised mucous membrane of the nose and blood in various forms of vasomotor rhinitis]. 61
5427806 1970
493
[Chronic bronchitis, vasomotor rhinitis and allergic manifestations on the respiratory organs and tissues in the population of Kriva Feja]. 61
5202438 1969
494
[Use of epsilon-aminocapromic acid in the treatment of vasomotor rhinitis]. 61
5375865 1969
495
[Vidian nerve surgery in treatment of vasomotor rhinitis]. 61
5398082 1969
496
[Operative treatment of allergic and vasomotor rhinitis. 2. Evaluation of Takehashi's intranasal rhinoplasty]. 61
5817279 1969
497
Aerosol corticosteroid treatment of vasomotor rhinitis. 61
4888643 1969
498
[Value of pernasal vaccination in the treatment of hay fever and vasomotor rhinitis]. 61
5805567 1969
499
[Use of ultrasound and hydrocortisone phonophoresis in the treatment of vasomotor rhinitis]. 61
5405545 1969
500
Experiences in the treatment of vasomotor rhinitis. 61
4385415 1968
501
[Allergic and vasomotor rhinitis]. 61
5187422 1968
502
[Vasomotor rhinitis]. 61
5190354 1968
503
[Inhalations of extracts from Gingko biloba in vasomotor rhinitis and in the bronchitic syndrome]. 61
5590539 1967
504
Vidian nerve section for vasomotor rhinitis. 61
6026951 1967
505
[Clinical symptoms and etiologic factors of allergic rhinitis or vasomotor rhinitis]. 61
5185217 1967
506
[Section of the vidian nerve in vasomotor rhinitis]. 61
5607790 1967
507
[Role of parasympathetic tonus in vasomotor rhinitis]. 61
6040939 1967
508
[On the behavior of the blood platelets in subjects with vasomotor rhinitis]. 61
5998167 1966
509
Treatment of chronic vasomotor rhinitis with clinico-pathological study of vidian nerve section in 150 cases. 61
5920568 1966
510
[Relation of vasomotor rhinitis to the spastic broncho-pulmonary syndrome in spirographic examination]. 61
5945990 1966
511
[Nonallergic vasomotor rhinitis]. 61
5322485 1965
512
[Chronic vasomotor rhinitis]. 61
5324145 1965
513
Vasomotor rhinitis. 61
5827892 1965
514
Nasal stuffiness with discharge or vasomotor rhinitis and hyperinsulinism. 61
5897837 1965
515
Rhinological methods for controlling nasal polyposis and vasomotor rhinitis. 61
5846540 1965
516
[Surgical treatment of patients with vasomotor rhinitis and comparative characterization of microscopic findings in the nasal tissues]. 61
5876612 1965
517
[DAPHNIA AS ONE OF THE POSSIBLE ALLERGENS IN THE PATHOGENESIS OF ALLERGIC FORMS OF VASOMOTOR RHINITIS]. 61
14300550 1965
518
[EXPERIENCES IN THE USE OF DEXA-RHINOSPRAY IN VASOMOTOR RHINITIS]. 61
14311769 1965
519
[CONTRIBUTION TO THE TREATMENT OF PERENNIAL ALLERGIC OR VASOMOTOR RHINITIS]. 61
14276848 1965
520
[BEHAVIOR OF MAST CELLS IN MUCOSA OF THE INFERIOR TURBINATE UNDER NORMAL CONDITIONS AND IN VASOMOTOR RHINITIS. (STUDY OF NUMERICAL, MORPHOLOGICAL AND HISTOCHEMICAL CHARACTERISTERIC CHANGES)]. 61
14343007 1965
521
[TREATING VASOMOTOR RHINITIS WITH PSYCHOPHARMACEUTICAL DRUGS]. 61
14305863 1965
522
[THE USE OF HISTAGLOBIN IN VASOMOTOR RHINITIS]. 61
14293181 1965
523
MANAGEMENT OF NASAL OBSTRUCTION IN VASOMOTOR RHINITIS AND NASAL POLYPOSIS. 61
14263671 1965
524
[Recent experiences in the treatment of vasomotor rhinitis]. 61
5329611 1965
525
Rhinological methods for controlling nasal polyposis and vasomotor rhinitis. 61
5862571 1965
526
[Significance of infection in the allergic diseases of the respiratory tracts. II. Microbial flora in the respiratory tracts of patients in bronchial asthma and vasomotor rhinitis]. 61
5886423 1965
527
[The significance of infection for allergic disorders of the respiratory tract. 3. Skin and organ sensitivity in patients with bronchial asthma and vasomotor rhinitis]. 61
5887933 1965
528
[The significance of infection for the allergic disorders of the respiratory tract. IV. The results of immunotherapy in patients with bronchial asthma and vasomotor rhinitis]. 61
5887935 1965
529
PHYSIOGENIC AND PSYCHOGENIC FACTORS IN VASOMOTOR RHINITIS. 61
14212246 1964
530
[APROPOS OF SOME DIAGNOSTIC SIGNS OF VASOMOTOR RHINITIS]. 61
14322297 1964
531
[ON THE TREATMENT OF PATIENTS WITH VASOMOTOR RHINITIS WITH SOME NEW ANTIHISTAMINIC PREPARATIONS]. 61
14252959 1964
532
[EXAMINATION OF ALLERGEN TESTS IN VASOMOTOR RHINITIS]. 61
14144795 1964
533
[THE RELATIONS OF VASOMOTOR RHINITIS TO BRONCHIAL ASTHMA]. 61
14162886 1964
534
[RESULTS OBTAINED WITH NISOREX IN VASOMOTOR RHINITIS AND A M'ENI'ERE-LIKE SYNDROME OF ALLERGIC ORIGIN]. 61
14162884 1964
535
[OUR EXPERIENCE ON TREATMENT OF VASOMOTOR RHINITIS WITH LOCAL INFILTRATIONS OF CORTICOSTEROIDS]. 61
14302881 1964
536
AGE AND SEX IN ATOPIC AND NON-ATOPIC VASOMOTOR RHINITIS (OUT-PATIENTS' VISITS AND ATOPIZATION TO HOUSE-DUST AND POLLEN). 61
14233636 1964
537
[ULTRASONICS IN THE TREATMENT OF VASOMOTOR RHINITIS]. 61
14202954 1964
538
[Treatment of vasomotor rhinitis with local phenylbutazone]. 61
14027239 1963
539
[THE ASSOCIATION OF AN ANTIHISTAMINIC WITH A THYMOLEPTIC DRUG IN THE SYMPTOMATIC THERAPY OF POLLINOSIC VASOMOTOR RHINITIS]. 61
14083040 1963
540
[ROENTGENOLOGICAL STUDY IN THE DIAGNOSIS OF VASOMOTOR RHINITIS]. 61
14054000 1963
541
[Contribution to vasomotor rhinitis and its treatment]. 61
13947258 1963
542
[Vascular reactivity in patients with vasomotor rhinitis]. 61
14024671 1963
543
[THE PATHOGENESIS OF ATTACKS OF VASOMOTOR RHINITIS OF ALLERGIC ORIGIN]. 61
14114306 1963
544
VASOMOTOR RHINITIS AND ITS MANAGEMENT. 61
14097532 1963
545
Pathology and surgery of chronic vasomotor rhinitis. 61
13948739 1962
546
[The clinical aspects and prevention of vasomotor rhinitis]. 61
14024670 1962
547
[On the therapy of vasomotor rhinitis]. 61
13975556 1962
548
Climatic and racial factors in vasomotor rhinitis. 61
13957518 1962
549
[On the problem of the mechanism of action of acupucture and on the effectivensess of the treatment in patients with various forms of vasomotor rhinitis]. 61
13883153 1962
550
[Treatment of vasomotor rhinitis and hay fever with Nisorex]. 61
13915928 1962
551
[On constitutional eczema with/without bronchial asthma and/or vasomotor rhinitis (synonyms: neurodermitis, endogenous eczema, etc.)]. 61
14489145 1962
552
[Treatment of vasomotor rhinitis with local administrations of Rheopyrin]. 61
13885698 1962
553
[On the problem of the condition of serum proteins in patients with vasomotor rhinitis]. 61
13899630 1962
554
Drug therapy of vasomotor rhinitis and asthma: dibenzheptropine, a valuable adjuvant in the corticoid treatment. 61
13926728 1962
555
[Clinical climatotherapy of constitutional eczema with and without bronchial asthma and/or vasomotor rhinitis at the North Sea]. 61
14489144 1962
556
Interrelation of asthma and vasomotor rhinitis, occurring in patients with housedust atopy. III. In respect to the localization of the symptoms. 61
13926727 1962
557
[New ideas concerning the pathogenesis of vasomotor rhinitis]. 61
13891173 1962
558
[Etiology and prevention of vasomotor rhinitis (neurovegetative and allergic)]. 61
14488613 1961
559
[The effect of climate and housing on patients with bronchial asthma and vasomotor rhinitis]. 61
13924822 1961
560
[Surface intranasal novocaine block in the treatment of vasomotor rhinitis]. 61
14464547 1961
561
[Results of treatment with Nisorex in vasomotor rhinitis]. 61
13909340 1961
562
Zinc ionization and vasomotor rhinitis. 61
13901304 1961
563
Observations on petrosal and vidian neurectomy in chronic vasomotor rhinitis. 61
13706533 1961
564
[Experience in the treatment of patients with vasomotor rhinitis with acupuncture]. 61
13706382 1961
565
Histology of vasomotor rhinitis. 61
13779281 1960
566
[Phenylbutazone in vasomotor rhinitis]. 61
13788555 1960
567
Intranasal injection of corticosteroids. 61
14446887 1960
568
[On the problem of the treatment of vasomotor rhinitis. (Preliminary communication)]. 61
13737127 1960
569
Interrelation of vasomotor rhinitis and asthma, occurring in patients with housedustatopy. 2. Influence of houses lived in. 61
13841298 1960
570
[Is vasomotor rhinitis due to cold an allergy?]. 61
13849591 1960
571
Clinical evaluation of parabromdylamine maleate (dimetane) in allergic and vasomotor rhinitis. 61
13819353 1959
572
[Our experience with the treatment of vasomotor rhinitis with novocaine]. 61
14412817 1959
573
[Treatment of vasomotor rhinitis with intra-turbinal injection of calcium-antihistaminic]. 61
13797442 1959
574
[Result of the treatment of vasomotor rhinitis by endonasal injections of novocaine with 5% alcoholic solution]. 61
13647929 1959
575
[Treatment of vasomotor rhinitis with the intraturbinal injection of calcium and an antihistaminic]. 61
13797443 1959
576
[First historical mention of allergic affections (vasomotor rhinitis and urticaria)]. 61
14442309 1959
577
Vasomotor rhinitis of pregnancy. 61
13616279 1958
578
[Study on therapy of vasomotor rhinitis]. 61
13613228 1958
579
[Plimasin & sandosten calcium Sandoz in therapy of vasomotor rhinitis]. 61
13585445 1958
580
[Action of nebulized prednisolone in vasomotor rhinitis & its inhibitory effect on the nasobronchial reflex in asthmatic patients]. 61
13573988 1958
581
[Hydrocortisone, antibiotics and vasoconstrictor drugs in allergic and vasomotor rhinitis]. 61
13552411 1958
582
Reflective reactions of the nasal mucosa in vasomotor rhinitis. 61
13434903 1957
583
Allergic vasomotor rhinitis. 61
13429914 1957
584
HYPOMETABOLISM as a cause of vasomotor rhinitis. 61
13384448 1957
585
[Practical experiences with paspat in the treatment of allergic vasomotor rhinitis]. 61
13358504 1956
586
[Treatment of vasomotor rhinitis]. 61
13344011 1956
587
[The syndrome of vasomotor rhinitis; etiological classification and effective therapy]. 61
13337754 1956
588
Studies in the endocrinopathic type of vasomotor rhinitis: preliminary report. 61
13306884 1956
589
Vasomotor rhinitis in hypertension. 61
13296500 1956
590
[Sleep therapy in vasomotor rhinitis]. 61
13325249 1956
591
[Therapeutical experiences in vasomotor rhinitis with special reference to antihistaminics]. 61
13293973 1955
592
The treatment of chronic vasomotor rhinitis. 61
13253098 1955
593
[Vasomotor rhinitis of non allergic origin]. 61
13254456 1955
594
Vasomotor rhinitis. 61
14388570 1955
595
[Various forms of chronic vasomotor rhinitis]. 61
13246319 1955
596
Controlled studies in the topical application of hydrocortisone in vasomotor rhinitis. 61
13249278 1955
597
Chronic vasomotor rhinitis. 61
14358891 1955
598
Satisfactory management of vasomotor rhinitis. 61
13233144 1955
599
Some rhinological syndromes and vasomotor rhinitis. 61
14354999 1955
600
Some rhinological syndromes and vasomotor rhinitis. 61
13311963 1955
601
Vasomotor rhinitis. 61
13281883 1955
602
Allergic examination and antiallergic treatment of vasomotor rhinitis. 61
14397979 1955
603
Results of treatment of vasomotor rhinitis with hyposensitization. 61
14397980 1955
604
Problems in vasomotor rhinitis. 61
13157722 1954
605
Vasomotor rhinitis and bronchial asthma due to Locust Bean Gum dust. 61
13148984 1954
606
Results of treatment of chronic vasomotor rhinitis. I. Response to physical treatment. 61
13126554 1954
607
Results of treatment of chronic vasomotor rhinitis. II. Response to psychological treatment. 61
13126555 1954
608
[The use of insulin subshock in the treatment of vasomotor rhinitis]. 61
13123034 1953
609
Rhinoplasty; psychogenic adjunct in the treatment of vasomotor rhinitis. 61
13058068 1953
610
The vasomotor rhinitis syndrome. 61
13049699 1953
611
[Result of application of dimedrol in vasomotor rhinitis]. 61
13090512 1953
612
Chronic vasomotor rhinitis; treatment by submucous diathermic coagulation. 61
13039666 1953
613
[Morphological peculiarities of secretion from the nose, nasal mucosa, and nasal polypi in vasomotor rhinitis]. 61
13090508 1953
614
[Results of the treatment of vasomotor rhinitis with intravenous novocaine with atropine]. 61
13090533 1953
615
[Diagnosis and therapy of vasomotor rhinitis]. 61
13086948 1953
616
[Combination ultrasonic therapy of vasomotor rhinitis]. 61
13086960 1953
617
[New experiences with sclerosin therapy of vasomotor rhinitis]. 61
13139566 1953
618
Treatment of hay fever, vasomotor rhinitis and vasomotor sinusitis with sodium psylliate; 900 cases. 61
13001219 1952
619
[Therapy of vasomotor rhinitis]. 61
13002323 1952
620
[Combined therapy of vasomotor rhinitis with submucous calcium injections and antihistaminics]. 61
14951589 1952
621
[Effect of soventol on hay fever and vasomotor rhinitis]. 61
14862976 1951
622
Differential diagnosis of vasomotor rhinitis. 61
14855113 1951
623
The management of vasomotor rhinitis. 61
14852712 1951
624
[Contribution to the study of vasomotor rhinitis]. 61
14825951 1951
625
[Vasomotor rhinitis]. 61
14845042 1951
626
[Vasomotor rhinitis in asthma following stellectomy]. 61
14874878 1951
627
[Initial results in the treatment of allergic vasomotor rhinitis by the Lewin-Wassen method (combined DOCA-ascorbic acid)]. 61
14929553 1951
628
[Submucosal and intracavernous endonasal calcium therapy in vasomotor rhinitis]. 61
14843950 1951
629
Vasomotor rhinitis. 61
15428946 1950
630
The approach to vasomotor rhinitis. 61
15431114 1950
631
The use of a combination of two antihistaminic drugs in the treatment of allergic vasomotor rhinitis. 61
15419583 1950
632
Vasomotor rhinitis. 61
15412485 1950
633
Vasomotor rhinitis. 61
14846105 1950
634
Treatment of allergic and vasomotor rhinitis with hesperidin chalcone sodium. 61
15394994 1949
635
The management of vasomotor rhinitis. 61
18894292 1948
636
Vasomotor rhinitis and homeopathic treatment. 61
18890883 1948
637
A psychosomatic approach to vasomotor rhinitis. 61
18890231 1948
638
Turbinate treatment in vasomotor rhinitis. 61
18879969 1948
639
Chronic vasomotor rhinitis in pregnancy. 61
20242982 1947
640
Observations on the management of vasomotor rhinitis. 61
20294991 1947
641
Further observations on the use of benadryl in hay fever, asthma, vasomotor rhinitis, and in mixed allergic groups. 61
20291905 1947
642
Non-specific desensitization in vasomotor rhinitis and asthma by scorpion venom. 61
20247939 1947
643
Vasomotor rhinitis medicamentosa viewed histologically. 61
20290038 1947
644
Chronic vasomotor rhinitis in pregnancy. 61
20291340 1947
645
Perennial vasomotor rhinitis; a modern approach to diagnosis and treatment. 61
20278786 1947
646
Benadryl in hay fever, asthma, and vasomotor rhinitis. 61
20988778 1946
647
Vasomotor rhinitis; treatment by submucous injection of phenol. 61
20282096 1946
648
The syndrome of physical or intrinsic allergy of the head; vasomotor rhinitis and the vasodilating pain syndrome, their relationship to myalgia and endolymphatic hydrops (Ménière's disease) and the reasons for including all four as the syndrome of physical allergy of the head. 61
21012897 1946
649
Vasomotor rhinitis. 61
21011217 1945
650
Electrocoagulation in vasomotor rhinitis. 61
21012423 1945
651
Vasomotor Rhinitis. 61
20323413 1945
652
The roentgen treatment of vasomotor rhinitis. 61
21005029 1945
653
Vasomotor Rhinitis: (Section of Laryngology). 61
19991366 1938
654
INTRANASAL TREATMENT BY IONIZATION IN HAY FEVER, VASOMOTOR RHINITIS, AND OZAENA. 61
20776807 1932
655
The Use of Carbon Dioxide in the Treatment of Vasomotor Rhinitis, Hay Fever and Asthma. 61
19987958 1931

Variations for Vasomotor Rhinitis

Expression for Vasomotor Rhinitis

Search GEO for disease gene expression data for Vasomotor Rhinitis.

Pathways for Vasomotor Rhinitis

GO Terms for Vasomotor Rhinitis

Cellular components related to Vasomotor Rhinitis according to GeneCards Suite gene sharing:

(showing 3, show less)
# Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.56 TAC1 RNASE3 NPY KNG1 IL5 IL16
2 cell GO:0005623 9.55 TRPV1 TAC1 NPY KNG1 CALCA
3 extracellular region GO:0005576 9.32 VIP TAC1 RNASE3 NPY NPS KNG1

Biological processes related to Vasomotor Rhinitis according to GeneCards Suite gene sharing:

(showing 14, show less)
# Name GO ID Score Top Affiliating Genes
1 G protein-coupled receptor signaling pathway GO:0007186 9.8 VIP TAC1 OR10A2 NPY NPS KNG1
2 positive regulation of cytosolic calcium ion concentration GO:0007204 9.62 TRPV1 TAC1 KNG1 CALCA
3 regulation of blood pressure GO:0008217 9.61 TAC1 NPY CALCA
4 leukocyte cell-cell adhesion GO:0007159 9.54 CD40LG CALCA
5 cellular response to nerve growth factor stimulus GO:1990090 9.54 TRPV1 TAC1 CALCA
6 positive regulation of blood vessel diameter GO:0097755 9.52 VIP CALCA
7 vasodilation GO:0042311 9.51 KNG1 CALCA
8 detection of temperature stimulus involved in sensory perception of pain GO:0050965 9.49 TRPV1 CALCA
9 positive regulation of synaptic transmission, GABAergic GO:0032230 9.48 TAC1 NPS
10 negative regulation of heart rate GO:0010459 9.46 TRPV1 TAC1
11 neuropeptide signaling pathway GO:0007218 9.46 TAC1 NPY NPS CALCA
12 positive regulation of action potential GO:0045760 9.4 TAC1 NPS
13 response to pain GO:0048265 9.13 TRPV1 TAC1 CALCA
14 inflammatory response GO:0006954 9.1 TRPV1 TAC1 KNG1 IL5 CD40LG CALCA

Molecular functions related to Vasomotor Rhinitis according to GeneCards Suite gene sharing:

(showing 2, show less)
# Name GO ID Score Top Affiliating Genes
1 neuropeptide hormone activity GO:0005184 8.96 VIP NPY
2 hormone activity GO:0005179 8.8 VIP NPY CALCA

Sources for Vasomotor Rhinitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....